Successful chimeric antigen receptor T cell therapy in a case of primary testicular diffuse large-B-cell lymphoma with central nervous system progression

Nana Ping; Changju Qu; Lian Bai; Liqing Kang; Xiaochen Chen; Qian Wu; Fan Xia; Lei Yu; Hong Yao; Depei Wu; Zhengming Jin

doi:10.1080/10428194.2019.1605507

Successful chimeric antigen receptor T cell therapy in a case of primary testicular diffuse large-B-cell lymphoma with central nervous system progression

Leuk Lymphoma. 2019 Nov;60(11):2814-2816. doi: 10.1080/10428194.2019.1605507. Epub 2019 May 14.

Authors

Nana Ping^{1

2

3}, Changju Qu^{1

2

3}, Lian Bai⁴, Liqing Kang^{5

6}, Xiaochen Chen^{1

2

3}, Qian Wu^{1

2

3}, Fan Xia⁷, Lei Yu^{5

6}, Hong Yao⁸, Depei Wu^{1

2

3}, Zhengming Jin^{1

2

3}

Affiliations

¹ Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, PR China.
² Institute of Blood and Marrow Transplantation, Suzhou, PR China.
³ Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
⁴ Department of Hematology, Canglang Hospital of Suzhou, Suzhou, PR China.
⁵ Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, PR China.
⁶ School of Chemistry and Molecular Engineering, East China Normal University, Suzhou, PR China.
⁷ Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, PR China.
⁸ Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, PR China.

PMID: 31088197
DOI: 10.1080/10428194.2019.1605507

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Central Nervous System Neoplasms / etiology
Central Nervous System Neoplasms / pathology
Central Nervous System Neoplasms / therapy*
Humans
Immunotherapy / adverse effects*
Immunotherapy, Adoptive / methods*
Lymphoma, Large B-Cell, Diffuse / immunology
Lymphoma, Large B-Cell, Diffuse / pathology
Lymphoma, Large B-Cell, Diffuse / therapy*
Male
Middle Aged
Neoplasm Recurrence, Local / etiology
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / therapy*
Prognosis